Mirena 52 MG systems
Ended Awarded
- Contract number
- SPE2DB26FSU87
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,604
Award facts
- Contract value 100% obligated
- $2,603.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,603.85 to DMS Pharmaceutical Group Inc. for Mirena 52 mg contraceptive systems on October 28, 2025, with an ultimate completion date of November 19, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating its competitive capability in unrestricted federal procurement. The delivery order was issued without subcontractor involvement and represents one of numerous pharmaceutical supply orders DMS has received from DLA's Medical Supply Chain division.
This delivery order was issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to ensure consistent pharmaceutical supply to Department of Defense military healthcare facilities worldwide. The IDC, designated SPE2DR and awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, structured with a 30-month base period and three 30-month option periods. Through this vehicle, DLA has authorized DMS to supply an extensive range of pharmaceuticals including branded and generic prescription drugs, biologics, vaccines, specialty pharmaceuticals, and medical consumables to support recurring DoD medical supply requirements globally.
Quick answers
Who was awarded contract SPE2DB26FSU87?
SPE2DB26FSU87 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FSU87 worth?
The government has obligated $2,604 on SPE2DB26FSU87.
Is contract SPE2DB26FSU87 an order under another contract?
Yes. SPE2DB26FSU87 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.
Was contract SPE2DB26FSU87 competed?
The extent of competition for SPE2DB26FSU87 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award